UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Bank of New Hampshire

Bank of New Hampshire decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,434 shares of the healthcare conglomerate’s stock after selling 62 shares during the quarter. UnitedHealth Group makes up about 1.6% of Bank of New Hampshire’s holdings, making the stock its 12th largest position. Bank of New Hampshire’s holdings in UnitedHealth Group were worth $5,493,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Lyell Wealth Management LP grew its stake in UnitedHealth Group by 8.0% in the 4th quarter. Lyell Wealth Management LP now owns 6,350 shares of the healthcare conglomerate’s stock worth $3,343,000 after acquiring an additional 470 shares during the period. Disciplined Equity Management Inc. boosted its holdings in shares of UnitedHealth Group by 14.1% in the fourth quarter. Disciplined Equity Management Inc. now owns 2,254 shares of the healthcare conglomerate’s stock valued at $1,187,000 after acquiring an additional 279 shares in the last quarter. Bailard Inc. lifted its stake in UnitedHealth Group by 1.1% during the fourth quarter. Bailard Inc. now owns 78,661 shares of the healthcare conglomerate’s stock valued at $41,413,000 after purchasing an additional 829 shares during the last quarter. BIP Wealth LLC lifted its position in shares of UnitedHealth Group by 51.1% in the 4th quarter. BIP Wealth LLC now owns 621 shares of the healthcare conglomerate’s stock valued at $327,000 after acquiring an additional 210 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. increased its stake in UnitedHealth Group by 3.8% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 78,480 shares of the healthcare conglomerate’s stock valued at $41,317,000 after buying an additional 2,873 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Piper Sandler boosted their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Up 0.2 %

Shares of UNH traded up $0.83 during trading hours on Friday, hitting $494.69. The company had a trading volume of 1,020,163 shares, compared to its average volume of 4,486,814. The company’s fifty day moving average price is $486.36 and its two-hundred day moving average price is $514.42. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The company has a market capitalization of $455.15 billion, a PE ratio of 30.18, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.26 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.